Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 39.840
- +1.490+3.89%
Close Dec 20 16:00 ET
- 40.339
- +0.499+1.25%
Post 20:01 ET
142.94MMarket Cap-5.50P/E (TTM)
41.640High36.350Low469.15KVolume36.780Open38.350Pre Close18.39MTurnover27.46%Turnover RatioLossP/E (Static)3.59MShares41.64052wk High2.85P/B68.08MFloat Cap6.76052wk Low--Dividend TTM1.71MShs Float937.748Historical High--Div YieldTTM13.79%Amplitude6.760Historical Low39.188Avg Price1Lot Size
Aligos Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 6.38%74.92M | 4.07%94.54M | 8.91%112.74M | 7.85%135.7M | 7.85%135.7M | -50.51%70.43M | -42.99%90.84M | -43.50%103.52M | -34.03%125.83M | -34.03%125.83M |
| -Cash and cash equivalents | -49.83%35.33M | -50.37%45.08M | -69.30%24.15M | 66.82%135.7M | 66.82%135.7M | -18.52%70.43M | 27.62%90.83M | -24.76%78.67M | -56.46%81.35M | -56.46%81.35M |
| -Short-term investments | --39.59M | 494,480.00%49.46M | 256.56%88.59M | --0 | --0 | --0 | -99.99%10K | -68.41%24.85M | 1,035.27%44.48M | 1,035.27%44.48M |
| Restricted cash | 48.65%110K | 66.67%70K | -45.59%216K | -39.13%70K | -39.13%70K | -7.50%74K | 100.00%42K | -74.53%397K | -29.88%115K | -29.88%115K |
| Other current assets | 15.70%4.79M | 47.61%4.96M | -7.38%5.11M | -30.16%5.31M | -30.16%5.31M | -46.30%4.14M | -59.58%3.36M | -46.42%5.52M | -43.79%7.6M | -43.79%7.6M |
| Total current assets | 6.94%79.82M | 5.65%99.57M | 7.89%118.06M | 5.65%141.08M | 5.65%141.08M | -50.27%74.64M | -43.80%94.24M | -43.90%109.43M | -34.67%133.55M | -34.67%133.55M |
| Non current assets | ||||||||||
| Net PPE | -24.72%7.97M | -23.56%8.61M | -21.10%9.21M | -21.54%9.82M | -21.54%9.82M | -20.54%10.59M | -20.81%11.26M | -20.98%11.68M | -16.40%12.51M | -16.40%12.51M |
| -Gross PPE | -8.48%19.51M | -8.24%19.9M | -4.96%20.62M | -6.83%20.57M | -6.83%20.57M | -4.70%21.32M | -4.58%21.69M | -4.47%21.7M | -0.67%22.08M | -0.67%22.08M |
| -Accumulated depreciation | -7.54%-11.54M | -8.31%-11.29M | -13.84%-11.41M | -12.41%-10.76M | -12.41%-10.76M | -18.64%-10.73M | -22.56%-10.43M | -26.27%-10.02M | -31.75%-9.57M | -31.75%-9.57M |
| Other non current assets | 1.93%635K | 1.12%631K | -1.11%625K | -1.42%625K | -1.42%625K | -4.59%623K | 1.30%624K | 2.60%632K | -26.79%634K | -26.79%634K |
| Total non current assets | -23.24%8.6M | -22.26%9.24M | -20.07%9.84M | -20.57%10.44M | -20.57%10.44M | -19.80%11.21M | -19.89%11.89M | -20.04%12.31M | -57.51%13.15M | -57.51%13.15M |
| Total assets | 3.00%88.43M | 2.53%108.81M | 5.06%127.9M | 3.30%151.53M | 3.30%151.53M | -47.67%85.85M | -41.85%106.13M | -42.16%121.74M | -37.68%146.69M | -37.68%146.69M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -1.68%9.75M | 1.16%12.58M | -28.10%8.99M | -25.34%9.66M | -25.34%9.66M | -5.94%9.91M | 9.07%12.43M | -31.01%12.5M | -37.09%12.94M | -37.09%12.94M |
| -accounts payable | -6.83%2.74M | 110.40%6.82M | 0.71%2.84M | -46.87%2.52M | -46.87%2.52M | 0.34%2.94M | 17.34%3.24M | -24.85%2.82M | 57.11%4.74M | 57.11%4.74M |
| -Other payable | 0.49%7.01M | -37.36%5.76M | -36.49%6.15M | -12.91%7.14M | -12.91%7.14M | -8.36%6.97M | 6.43%9.19M | -32.63%9.68M | -53.27%8.2M | -53.27%8.2M |
| Current accrued expenses | 118.19%2.75M | 87.86%2.71M | 25.03%2.84M | 105.36%3.03M | 105.36%3.03M | 38.05%1.26M | 68.34%1.44M | 98.69%2.27M | 19.27%1.47M | 19.27%1.47M |
| Current debt and capital lease obligation | 4.45%3.4M | 3.65%3.36M | 3.97%3.27M | 3.05%3.24M | 3.05%3.24M | 1.50%3.26M | 10.33%3.24M | -4.43%3.15M | 8.12%3.14M | 8.12%3.14M |
| -Current capital lease obligation | 4.45%3.4M | 3.65%3.36M | 3.97%3.27M | 3.05%3.24M | 3.05%3.24M | 1.50%3.26M | 10.33%3.24M | -4.43%3.15M | 8.12%3.14M | 8.12%3.14M |
| Current deferred liabilities | -83.42%655K | -80.93%1.33M | -89.74%721K | -85.80%1.31M | -85.80%1.31M | -63.17%3.95M | -47.06%6.95M | -53.36%7.03M | 20.53%9.21M | 20.53%9.21M |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | -91.95%7K | -80.92%25K | -76.04%46K | -76.09%66K | -76.09%66K |
| Current liabilities | -6.73%20.96M | -13.45%23.56M | -32.76%18.88M | -27.84%23.91M | -27.84%23.91M | -26.43%22.47M | -13.99%27.23M | -32.10%28.08M | -14.96%33.13M | -14.96%33.13M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -32.69%5.73M | -29.37%6.48M | -18.21%7.21M | -16.24%7.9M | -16.24%7.9M | -13.32%8.52M | -12.62%9.18M | -20.45%8.82M | -18.33%9.43M | -18.33%9.43M |
| -Long term capital lease obligation | -32.69%5.73M | -29.37%6.48M | -18.21%7.21M | -16.24%7.9M | -16.24%7.9M | -13.32%8.52M | -12.62%9.18M | -20.45%8.82M | -18.33%9.43M | -18.33%9.43M |
| Non current deferred liabilities | ---- | ---- | ---- | --0 | --0 | --0 | -97.14%93K | -98.14%93K | --233K | --233K |
| Derivative product liabilities | --11.6M | --11.49M | --41.97M | --27.6M | --27.6M | ---- | ---- | ---- | --0 | --0 |
| Other non current liabilities | 0.00%46K | --46K | --46K | --46K | --46K | -65.41%46K | ---- | ---- | ---- | ---- |
| Total non current liabilities | 102.90%17.37M | 94.37%18.02M | 452.54%49.23M | 267.77%35.54M | 267.77%35.54M | -25.64%8.56M | -33.26%9.27M | -45.10%8.91M | -17.27%9.66M | -17.27%9.66M |
| Total liabilities | 23.52%38.33M | 13.94%41.58M | 84.13%68.11M | 38.92%59.45M | 38.92%59.45M | -26.22%31.03M | -19.87%36.5M | -35.77%36.99M | -15.49%42.79M | -15.49%42.79M |
| Shareholders'equity | ||||||||||
| Share capital | 100.00%8K | 100.00%8K | 75.00%7K | 75.00%7K | 75.00%7K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K |
| -common stock | 100.00%8K | 100.00%8K | 75.00%7K | 75.00%7K | 75.00%7K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K | 0.00%4K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -16.77%-535.86M | -17.18%-516.6M | -23.59%-521.66M | -21.97%-486.8M | -21.97%-486.8M | -21.65%-458.91M | -22.94%-440.86M | -24.62%-422.07M | -31.69%-399.12M | -31.69%-399.12M |
| Paid-in capital | 14.06%585.37M | 14.38%583.33M | 14.74%580.97M | 15.06%578.33M | 15.06%578.33M | 2.83%513.23M | 2.92%510M | 3.04%506.32M | 3.13%502.61M | 3.13%502.61M |
| Gains losses not affecting retained earnings | 16.10%577K | -0.60%494K | -4.61%476K | 35.91%545K | 35.91%545K | 212.58%497K | 894.00%497K | 144.61%499K | -11.28%401K | -11.28%401K |
| Total stockholders'equity | -8.62%50.1M | -3.46%67.23M | -29.44%59.8M | -11.38%92.08M | -11.38%92.08M | -55.07%54.82M | -49.16%69.64M | -44.57%84.75M | -43.76%103.9M | -43.76%103.9M |
| Total equity | -8.62%50.1M | -3.46%67.23M | -29.44%59.8M | -11.38%92.08M | -11.38%92.08M | -55.07%54.82M | -49.16%69.64M | -44.57%84.75M | -43.76%103.9M | -43.76%103.9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |